Elevance Health reports Q1 revenues at $42.3 billion, surpassing expectations. CEO Gail Boudreaux highlights strategic growth initiatives, with profit up 12.2% Y/Y and adjusted EPS at $10.64. Medicaid membership decline offset by commercial and ACA enrollment.
Apogee Enterprises shines in Q4 FY24, surpassing expectations with robust sales growth of 5.2% year-on-year, reaching $361.84 million. The company's strategic initiatives, including enhanced pricing and optimized product mix, drove a notable 13.3% increase in gross profit to $88.5 million, marking a gross margin improvement of 170 bps to 24.4%.
MYT Netherlands Parent B.V. (NYSE:MYTE) ("Mytheresa" or the "Company"), today announced preliminary unaudited financial results for the third quarter ended March 31, 2024, and confirmed the guidance for the full fiscal
2024 Outlook (1) Q1 2024 UpdatedGuidance Initial GuidanceNet Income Attributable to Common Stockholders per diluted share $1.17 - $1.20 $1.11 - $1.14Company share of Core FFO per diluted